Summary
Erythrocyte glutathione reductase activity was assayed in animals bearing Walker, Ehrlich, and Krebs tumors, 21 days after implantation. It was noticed that the activity was significantly enhanced in all three tumors.
Article PDF
Avoid common mistakes on your manuscript.
References
Arnold H, Blume KG, Lohr GW, Boulard M, Najean Y (1974) Acquired red cell enzyme defects in hematological diseases. Clin Chim Acta 57:187–189
Berquó ES, Souza JMP, Gotlieb SLD (1980) Bioestatistica. Edit. Pedagógica Univ., São Paulo
Beutler E (1969) Glutathione reductase: stimulation in normal subjects by riboflavin supplementation. Science 165:613–615
Boivin P, Galand C, Hakim J, Kahn A (1975) Acquired erythroenzymopathies in blood disorders: study of 200 cases. Br J Haematol 31:531–544
Kahn A (1981) Abnormalities of erythrocyte enzymes in diserythropoiesis and malignancies. Clin Hematol 10:123–138
Kahn A, Cottreau D, Bernard JF, Boivin P (1975) Post-translational modifications of glucose-6-phosphate dehydrogenase in human leukemias. Biomedicine 22:539–549
Kosower NS, Kosower EM (1978) The glutathione status of cells. Int. Rev Cytol 54:109–160
Rochant H, Dreyfus B, Bouguerra M, Tont-Hat H (1972) Hypothesis: refractory anemia, pre-leukemia conditions, and fetal erythropoiesis. Blood 39:721–726
Valentine WN, Konrad PN, Paglia DE (1973) Dyserythropoiesis, refractory anemia and “pre-leukemia”: metabolic features of the erythrocytes. Blood 41:857–875
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Barretto, O.C.O., Zyngier, S.B. Acquired disturbance of erythrocyte glutathione reductase in experimental tumors. J Cancer Res Clin Oncol 108, 252–253 (1984). https://doi.org/10.1007/BF00402479
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00402479